5-Hexadecyl methotrexate
| Code | Size | Price |
|---|
| TAR-T29454-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
5-Hexadecyl methotrexate is a amphipathic analog of methotrexate.
CAS:
88887-42-7
Formula:
C36H54N8O5
Molecular Weight:
678.879
Purity:
0.98
SMILES:
CCCCCCCCCCCC(CCCC)OC(=O)[C@H](CCC(O)=O)NC(=O)c1ccc(cc1)N(C)Cc1cnc2nc(N)nc(N)c2n1
References
1. Shaw JM, Shaw KV. Key issues in the delivery of pharmacological agents using lipoproteins: design of a synthetic apoprotein-lipid carrier. Targeted Diagn Ther. 1991;5:351-83. PubMed PMID: 1665722.